The protein Succinate-CoA Ligase GDP-Forming Subunit Beta (SUCLG2) is a crucial enzyme involved in the tricarboxylic acid (TCA) cycle, also known as the citric acid cycle or Krebs cycle. This enzyme is encoded by the SUCLG2 gene and is primarily located in the mitochondria, the cellular powerhouse responsible for energy production.SUCLG2 plays a vital role in cellular energy metabolism by catalyzing the conversion of succinyl-CoA and GDP to succinate and GTP. This reaction is a key step in the TCA cycle, where it links the cycle to the production of energy-rich molecules such as GTP, which can subsequently be converted to ATP, the primary energy currency of the cell.
The TCA cycle is a central metabolic pathway that fuels the cell with energy and provides key intermediates for biosynthesis. SUCLG2's specific role is to facilitate the regeneration of succinate, an important intermediate of the TCA cycle, while concurrently producing GTP, an energy carrier molecule similar to ATP. The GTP produced by SUCLG2 can be used directly as an energy source or can be converted to ATP, amplifying the potential energy yield of the TCA cycle.Beyond energy metabolism, SUCLG2 has been implicated in various cellular processes, including heme biosynthesis, regulation of mitochondrial function, and cellular responses to stress. Dysregulation of SUCLG2 has been associated with metabolic disorders, mitochondrial dysfunction, and certain types of cancer, highlighting its significance in maintaining proper cellular function and health.Research into SUCLG2 continues to uncover its broader implications in cellular physiology and human disease. The enzyme's multifaceted role in energy production and its influence on other cellular processes underscore its importance in maintaining overall cellular homeostasis and functionality. Understanding the precise mechanisms and regulation of SUCLG2 may provide valuable insights into metabolic diseases.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Oxaloacetic Acid | 328-42-7 | sc-279934 sc-279934A sc-279934B | 25 g 100 g 1 kg | $306.00 $963.00 $7980.00 | 1 | |
As a TCA cycle intermediate, it might indirectly affect SUCLG2 through metabolic feedback mechanisms. | ||||||
Itaconic acid | 97-65-4 | sc-250207 sc-250207A | 100 g 1 kg | $29.00 $52.00 | ||
An immunomodulatory metabolite that can inhibit aconitase, possibly influencing SUCLG2 indirectly. | ||||||
2-Deoxy-D-glucose | 154-17-6 | sc-202010 sc-202010A | 1 g 5 g | $70.00 $215.00 | 26 | |
A glycolysis inhibitor, potentially influencing TCA cycle activity and indirectly affecting SUCLG2. | ||||||
3-Nitropropionic acid | 504-88-1 | sc-214148 sc-214148A | 1 g 10 g | $82.00 $459.00 | ||
An inhibitor of succinate dehydrogenase, potentially affecting succinate levels and thereby SUCLG2 activity. | ||||||
Dimethyl malonate | 108-59-8 | sc-239778 sc-239778A | 250 ml 1 L | $50.00 $104.00 | 1 | |
A malonate derivative that might act as a competitive inhibitor of succinate dehydrogenase, indirectly influencing SUCLG2. | ||||||
Rotenone | 83-79-4 | sc-203242 sc-203242A | 1 g 5 g | $89.00 $259.00 | 41 | |
An inhibitor of mitochondrial complex I, potentially affecting TCA cycle flux and indirectly SUCLG2 activity. | ||||||
Antimycin A | 1397-94-0 | sc-202467 sc-202467A sc-202467B sc-202467C | 5 mg 10 mg 1 g 3 g | $55.00 $63.00 $1675.00 $4692.00 | 51 | |
Inhibits mitochondrial complex III, potentially impacting TCA cycle activity and indirectly SUCLG2. | ||||||
Oligomycin | 1404-19-9 | sc-203342 sc-203342C | 10 mg 1 g | $149.00 $12495.00 | 18 | |
Targets ATP synthase, potentially affecting mitochondrial function and indirectly influencing SUCLG2. | ||||||